Literature DB >> 8717537

Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells.

M LInd1, E F Eriksen, C Bünger.   

Abstract

Bone morphogenetic proteins (BMPs) have important functions for the differentiation of bone cells, but the exact role for bone remodeling and bone healing still needs to be defined. Migration of bone forming cells is an important physiological event both during bone healing and bone remodeling. The chemotatic properties of the bone morphogenetic protein family of growth factors have not been investigated. In this study the chemotactic effects of the bone morphogenetic proteins BMP-2, -4, and -6 have been quantitated toward human osteoblasts, human marrow stromal osteoblasts, and U2-OS human osteosarcoma cells. BMP-2 stimulated the migration of human stromal osteoblasts, human osteoblasts, and U2-OS cells with bell-shaped response curves in a dose-dependent manner with a 300% increase in cell migration at 1.0 ng/mL for human stromal osteoblasts and a 170-180% increase for human osteoblasts and U2-OS cells. At higher concentrations, migration decreased to background levels. BMP-4 and -6 did not show any effect on cellular migration. This study shows that BMP-2 can stimulate in vitro migration of human osteoblasts and human osteosarcoma cells. BMP-2 might play a role in the chemotactic recruitment of especially undifferentiated osteoblasts during bone remodeling and bone healing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717537     DOI: 10.1016/8756-3282(95)00423-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  31 in total

Review 1.  Osteoblast migration in vertebrate bone.

Authors:  Antonia Thiel; Marie K Reumann; Adele Boskey; Johannes Wischmann; Rüdiger von Eisenhart-Rothe; Philipp Mayer-Kuckuk
Journal:  Biol Rev Camb Philos Soc       Date:  2017-06-19

2.  Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects.

Authors:  Lauren B Priddy; Ovijit Chaudhuri; Hazel Y Stevens; Laxminarayanan Krishnan; Brent A Uhrig; Nick J Willett; Robert E Guldberg
Journal:  Acta Biomater       Date:  2014-06-17       Impact factor: 8.947

3.  Enhanced Bone Repair by Guided Osteoblast Recruitment Using Topographically Defined Implant.

Authors:  Jeong-Kee Yoon; Hong Nam Kim; Suk Ho Bhang; Jung-Youn Shin; Jin Han; Wan-Geun La; Gun-Jae Jeong; Seokyung Kang; Ju-Ro Lee; Jaesur Oh; Min Sung Kim; Noo Li Jeon; Byung-Soo Kim
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

4.  An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenetic protein-2 in mesothelial cells and its tumor.

Authors:  Y Kiyozuka; H Miyazaki; K Yoshizawa; H Senzaki; D Yamamoto; K Inoue; K Bessho; Y Okubo; K Kusumoto; A Tsubura
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 5.  Scientific evidence on the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in oral and maxillofacial surgery.

Authors:  Pedro Henrique Silva Gomes-Ferreira; Roberta Okamoto; Sabrina Ferreira; Danila De Oliveira; Gustavo Antonio Correa Momesso; Leonardo Perez Faverani
Journal:  Oral Maxillofac Surg       Date:  2016-05-29

6.  Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects.

Authors:  Yash M Kolambkar; Joel D Boerckel; Kenneth M Dupont; Mehmet Bajin; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Bone       Date:  2011-05-18       Impact factor: 4.398

7.  A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model.

Authors:  Björn Behr; Michael Sorkin; Marcus Lehnhardt; Andrea Renda; Michael T Longaker; Natalina Quarto
Journal:  Tissue Eng Part A       Date:  2012-02-28       Impact factor: 3.845

Review 8.  Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing.

Authors:  Crispin R Dass; Eugene T H Ek; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-10       Impact factor: 4.553

9.  A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China.

Authors:  Ninghan Feng; Bin Xu; Jun Tao; Pengchao Li; Gong Cheng; Zhichao Min; Yuanyuan Mi; Meilin Wang; Na Tong; Jialin Tang; Zhengdong Zhang; Hongfei Wu; Wei Zhang; Zengjun Wang; Lixin Hua
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

10.  Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.

Authors:  Yong Park; Myoung Hee Kang; Hee Yeon Seo; Joong Min Park; Chul Won Choi; Yeul Hong Kim; In Sun Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.